AROA BIOSURGERY LIMITEDAROA BIOSURGERY LIMITEDAROA BIOSURGERY LIMITED

AROA BIOSURGERY LIMITED

No trades
See on Supercharts

Price target

0.940.000.00%
The 5 analysts offering 1 year price forecasts for ARX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to ARX in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


ARX EPS for the last quarter is −0.01 AUD despite the estimation of −0.01 AUD. In the next quarter EPS is expected to reach 0.00 AUD. Track more of AROA BIOSURGERY LIMITED financials and stay on top of what is up with the company.
In the next quarter AROA BIOSURGERY LIMITED revenue is expected to reach ‪42.07 M‬ AUD. Check out AROA BIOSURGERY LIMITED revenue and earnings and make informed decisions.
According to analysts, ARX price target is 0.94 AUD with a max estimate of 1.06 AUD and a min estimate of 0.76 AUD. Check if this forecast comes true in a year, meanwhile watch AROA BIOSURGERY LIMITED stock price chart and keep track of the current situation with ARX news and stock market news.
We've gathered opinions of 5 analysts rating ARX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.